• Ballsy Celgene Continues to Tread Carefully Into Neurosciences biospace
    January 29, 2018
    Two years ago during a lunch with a group of reporters at the J.P. Morgan confab, then Celgene CEO (now executive chairman) Bob Hugin got my attention with a comment on the importance of neurosciences in the pipeline.
PharmaSources Customer Service